Patent · US Active

Antibodies directed against ICOS for treating graft-versus-host disease

US9695247B2 · kind B2 · utility

2Cited by

2References

6Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
CENTRE LEON BERARD · FR
UNIVERSITÉ D'AIX-MARSEILLE · FR

Inventors

Gilles Marodon · Paris, FR
Daniel Olive · Marseilles, FR
Christine Menetrier-Caux · Val-de-Reuil, FR

Key dates

Filing date	Sep 3, 2013
Grant date	Jul 4, 2017
Priority date	—
Expiry date	Jul 9, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a specific antibody directed against, for use for treating graft versus host disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.